Stocks & Investing
Fri, October 4, 2024
[ 12:00 AM ] - WOPRAI
Tue, September 24, 2024
[ 12:00 AM ] - WOPRAI
Tue, September 17, 2024
[ 12:00 AM ] - WOPRAI
Wed, September 4, 2024
[ 12:00 AM ] - WOPRAI
Mon, August 12, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Fri, July 26, 2024
[ 12:00 AM ] - WOPRAI
Mon, July 8, 2024
Mon, June 24, 2024
[ 12:00 AM ] - WOPRAI
Tue, June 18, 2024
[ 12:00 AM ] - WOPRAI
Thu, May 23, 2024
[ 12:00 AM ] - WOPRAI
Wed, May 15, 2024
[ 12:00 AM ] - WOPRAI
Thu, May 9, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Fri, May 3, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Thu, April 11, 2024
[ 12:00 AM ] - WOPRAI
Mon, April 1, 2024
[ 12:00 AM ] - WOPRAI
Wed, March 27, 2024
[ 12:00 AM ] - WOPRAI
Fri, March 22, 2024
[ 12:00 AM ] - WOPRAI
Thu, March 21, 2024
[ 12:00 AM ] - WOPRAI
Fri, March 15, 2024
[ 12:00 AM ] - WOPRAI
Tue, March 12, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tue, February 20, 2024
[ 12:00 AM ] - WOPRAI
Thu, December 21, 2023
[ 12:00 AM ] - WOPRAI
Tue, December 19, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Derek Archila Initiated (atyr) at Buy and Held Target at $17 on, Oct 4th, 2024
Derek Archila of Wells Fargo, Initiated "aTyr Pharma, Inc." (ATYR) at Buy and Held Target at $17 on, Oct 4th, 2024.
Derek has made no other calls on ATYR in the last 4 months.
There are 3 other peers that have a rating on ATYR. Out of the 3 peers that are also analyzing ATYR, 0 agree with Derek's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Derek
- Roger Song of "Jefferies" Initiated at Strong Buy and Held Target at $9 on, Thursday, September 5th, 2024
- Joseph Pantginis of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $35 on, Thursday, August 15th, 2024
- Gregory Renza of "RBC Capital" Reiterated at Buy and Held Target at $16 on, Wednesday, August 14th, 2024
